Profit from the Regulated CBD Industry - HMRC Approved Investment

Medicaleaf™ is set to be Europe’s leading provider of health and wellness CBD innovations. A global brand promoting wellness from nature. Medicaleaf will have a 'post-raise' valuation of £20 million with expectations to reach a pre-floatation valuation of £100 million in three years' time, Annual predicted net profit over sales metric of ‘plus 43%'. DOWNLOAD YOUR INVESTMENT MEMORANDUM

MedicalLeaf are already at the forefront of CBD product development and are ready for the impending Gold Rush.

CLICK HERE TO LEARN MORE “Regulation on a global scale is coming. Cannabinoids are on the verge of being used in toothpaste, beverages, personal care products, and almost anything else you can imagine” Forbes | August 2020

Disclaimer: Any person accessing the email and considering potential investment opportunities featured on the email should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This email should not be construed as advice or a personal recommendation to any prospective investor.

Money Street News | 145 - 157 St John Street, London, EC1V 4PW United Kingdom Unsubscribe ssr4.sandyst@blogger.com Update Profile | Customer Contact Data Notice Sent by info@moneystreetnews.com powered by Try email marketing for free today!